-
Salicylate other than 5-aminosalicylic acid ineffective in ulcerative colitis.
Lancet. 1978 Nov 4;2(8097):993
PMID: 82016
-
Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease.
Gut. 1978 Oct;19(10):875-7
PMID: 101423
-
Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone.
Gut. 1979 Sep;20(9):802-5
PMID: 40848
-
The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis.
Acta Med Scand. 1979;206(6):451-7
PMID: 43662
-
Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes.
Biochem Pharmacol. 1980 Feb 15;29(4):533-8
PMID: 6245654
-
Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.
Br J Pharmacol. 1980 Apr;68(4):719-30
PMID: 6103724
-
Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
N Engl J Med. 1980 Dec 25;303(26):1499-502
PMID: 6107853
-
Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment.
Prostaglandins. 1981 Mar;21(3):417-25
PMID: 6112777
-
Ischemic injury in the cat small intestine: role of superoxide radicals.
Gastroenterology. 1982 Jan;82(1):9-15
PMID: 6273253
-
Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.
J Clin Invest. 1982 Feb;69(2):494-7
PMID: 6120182
-
Selective actions of aspirin- and sulphasalazine-like drugs against prostaglandin synthesis and breakdown.
Biochem Pharmacol. 1982 Mar 15;31(6):969-71
PMID: 6123327
-
Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils.
Clin Exp Immunol. 1982 Jul;49(1):247-55
PMID: 7127901
-
Arachidonic acid-induced chemiluminescence of human polymorphonuclear leukocytes.
Biochem Biophys Res Commun. 1982 Aug;107(3):779-84
PMID: 6814431
-
Increased hydroxyl radical generation by normal polymorphonuclear leukocytes incubated in sera from patients with leukocytoclastic vasculitis.
Arch Dermatol Res. 1982;274(1-2):65-71
PMID: 7165369
-
Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes.
Arch Dermatol Res. 1982;274(3-4):363-7
PMID: 7165380
-
Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leucocytes.
Arch Dermatol Res. 1983;275(1):23-6
PMID: 6847242
-
Hydroxyl-free radicals and anti-inflammatory drugs: biological inactivation studies and reaction rate constants.
Biochem Pharmacol. 1983 Jul 1;32(13):2109-11
PMID: 6307311
-
Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis.
Gastroenterology. 1984 Jun;86(6):1496-500
PMID: 6143704
-
Dissociation of the inhibitory effect of dapsone on the generation of oxygen intermediates--in comparison with that of colchicine and various scavengers.
Biochem Pharmacol. 1984 Aug 1;33(15):2355-60
PMID: 6087824
-
Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
Gut. 1984 Nov;25(11):1271-8
PMID: 6149981
-
Neutrophil-generated active oxygens in linear IgA bullous dermatosis.
Arch Dermatol. 1985 Jan;121(1):73-8
PMID: 3881090
-
Salazosulfapyridine and non-steroidal antiinflammatory drugs do not inhibit soybean lipoxygenase.
Biochem Pharmacol. 1985 Jan 1;34(1):148-9
PMID: 2857082
-
Auto-oxidative damage in cement dermatitis.
Arch Dermatol Res. 1985;277(4):288-92
PMID: 2988461
-
Erythema multiforme: a possible pathogenetic role of increased reactive oxygen species.
J Clin Lab Immunol. 1986 Jan;19(1):11-4
PMID: 3517342
-
Distribution studies of salicylazosulfapyridine and its metabolites.
Gastroenterology. 1973 Feb;64(2):240-5
PMID: 4405598
-
Effect of cytochalasin B on response of human polymorphonuclear leukocytes to zymosan.
J Cell Biol. 1973 Apr;57(1):237-40
PMID: 4691395
-
Drug therapy: Sulfasalazine.
N Engl J Med. 1975 Jul 3;293(1):20-3
PMID: 236516
-
Letter: Prostaglandins, ulcerative colitis, and sulphasalazine.
Lancet. 1975 Nov 15;2(7942):988
PMID: 53480
-
Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages.
Biochem Biophys Res Commun. 1976 Mar 8;69(1):245-52
PMID: 1259763
-
Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease.
J Clin Invest. 1976 Apr;57(4):836-41
PMID: 181401
-
Inhibition of superoxide anion production in macrophages by anti-inflammatory drugs.
Biochem Pharmacol. 1976 Jul 1;25(13):1473-80
PMID: 8043
-
H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells.
J Clin Invest. 1977 Dec;60(6):1266-79
PMID: 199619
-
An experiment to determine the active therapeutic moiety of sulphasalazine.
Lancet. 1977 Oct 29;2(8044):892-5
PMID: 72239
-
The biology and pathology of oxygen radicals.
Ann Intern Med. 1978 Jul;89(1):122-7
PMID: 208444
-
Ethylene formation by polymorphonuclear leukocytes. Role of myeloperoxidase.
J Exp Med. 1978 Aug 1;148(2):490-506
PMID: 212502
-
Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
Gastroenterology. 1978 Oct;75(4):638-40
PMID: 30669
-
Prostaglandins and ulcerative colitis.
Gastroenterology. 1979 May;76(5 Pt 1):1083
PMID: 374175